Stockreport

Zynerba Pharmaceuticals Announces Phase 3 RECONNECT Trial Design for Zygel™ in Fragile X Syndrome

Zynerba Pharmaceuticals, Inc.  (ZYNE) 
Last zynerba pharmaceuticals, inc. earnings: 3/10 06:50 am Check Earnings Report
US:NASDAQ Investor Relations: ir.zynerba.com
PDF - Confirmatory pivotal trial expected to be initiated in the third quarter of 2021 - - Zynerba to hold conference call today, May 5, 2021 at 5:30 pm ET - DEVON, Pa., M [Read more]